CIRIUM
The major US carriers made a clean sweep of the top four places as aviation analytics firm Cirium revealed its World Airline Passenger Rankings for 2021.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220831005886/en/
US majors take top spot while low-cost carriers rise up the Cirium global airlines rankings. (Graphic: Business Wire)
American Airlines stays on top of the ranking again in 2021, followed by Delta Air Lines, United Airlines and Southwest Airlines, demonstrating the strength of the recovery that continues to take place in the US domestic market.
Overall, airlines in North America showed 75% growth from the low point in 2020, although still ending last year down by 40% on 2019 traffic levels, as measured in Revenue Passenger Kilometers/Miles (RPKs/RPMs).
The ranking, which is based on over 600 operators tracked in the Cirium airline database, shows that world traffic ended 2021 down by 57% against the pre-pandemic peak. In terms of passenger numbers, the total stood at 2.3 billion for the year, representing around half of the volumes from the peak in 2019.
Low-cost carriers continued to rise up the rankings across the regions. Ryanair cemented its place as Europe’s largest carrier, sitting in fifth place just below Southwest, and was the only European airline to make it into the top 10.
Europe’s major network carriers have fared less well over the past couple of years, as demand for long-haul, premium travel remained depressed. Although Air France held steady at 13th place, Lufthansa slipped down the rankings and British Airways fell out of the top 20 altogether. Virgin Atlantic also dropped more than 50 places as it too suffered from the slow return of long-haul and premium traffic.
The big three carriers in mainland China – China Southern, China Eastern and Air China – held their place toward the top of the ranking, although that could change after a renewed round of COVID-19 lockdowns in Chinese cities so far this year.
Across Asia Pacific as a whole – in stark contrast to recovery in all other world regions – airlines saw traffic fall again last year. Cathay Pacific slipped spectacularly, falling out of the top 100 ranking entirely following Hong-Kong’s pursuit of an aggressive zero-COVID strategy. It was not alone. Carriers across the region in Indonesia, Malaysia, South Korea and Thailand also continued to shrink.
In Japan, All Nippon Airways and Japan Airlines had lost nearly 85% of their traffic in 2020 and were still down by around 75% by the end of 2021. Both fell steeply down the rankings as a result.
Jeremy Bowen, Cirium CEO, said: “Pre-pandemic, Asia Pacific airlines held the single largest share of global passenger traffic, with over a third of the world total. By 2021 the region was overtaken by North America, led by the strong recovery in domestic US flying.”
Two Gulf carriers, Emirates and Qatar Airways, both retained their position within the top 10 airlines, although the gap between them narrowed. Emirates slipped four places to sit just ahead of a rising Qatar Airways, which has made a point of maintaining as much of its network as possible.
Turkish Airlines, helped by an extensive domestic market free of cross-border travel restrictions, climbed four places to 10th in the latest ranking compared with 2019.
The Cirium ranking highlights the struggle which mainline carriers have faced, especially those relying on a strong mix of business travel and long-haul flying. By 2021 their share of world passenger traffic had slipped some five percentage points to 64%. That decline was largely picked up by low-cost carriers, who raised their share to 26%.
Cirium’s World Airline Passenger Ranking 2021 is a premium analysis available in Cirium Dashboard. The report features:
- The Top 200 airlines by passenger traffic
- The Top 50 airline groups by passenger traffic
- The Top 50 airlines by passenger volume
- Passenger traffic by region and by airline type 2019-2021
- Share of passenger traffic by airline region and airline type
- Share of passenger volume by airline type
Click here to download the full report.
Ends
About Cirium
Cirium brings together powerful data and analytics to keep the world moving. Delivering insight, built from decades of experience in the sector, enabling travel companies, aircraft manufacturers, airports, airlines and financial institutions, among others, to make logical and informed decisions which shape the future of travel, growing revenues and enhancing customer experiences. Cirium is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. The shares of RELX PLC are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX.
For further information please follow Cirium updates on LinkedIn or Twitter or visit www.cirium.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220831005886/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Volante Technologies Customers Successfully Navigate Critical Regulatory Deadlines for EU SEPA Instant and Global SWIFT Cross-Border Payments16.12.2025 10:00:00 CET | Press release
PaaS leader ensures seamless migrations and uninterrupted payment operations Volante Technologies, the global leader in Payments as a Service (PaaS), today announced it has successfully upgraded its clients to meet the latest SEPA Instant Payments Regulation (IPR) and SWIFT SRG 2025 mandate, which came into effect October 9th and November 22nd, 2025, respectively. This announcement follows the major FedISO upgrade in July, which shifted trillions of dollars in payments to the new ISO 20022 messaging format. SEPA IPR is a significant European milestone, requiring payments to be made within 10 seconds and at any time of day, throughout the year. Adoption was mandatory and Eurozone banks were compelled to meet strict deadlines, with January 9th, 2025 the deadline for receiving incoming instant payments and October 9th the deadline for sending outgoing instant payments. The latest deadline impacted more than 700 banks across Europe, with non-compliance penalties reaching at least 10% of an
TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth16.12.2025 09:05:00 CET | Press release
TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem™ is delighted to announce the appointment of skilled biotech leader, Mark Rothera, as Chief Executive Officer and Board member. He succeeds Frédéric Desdouits, who is stepping down after five years in the role. In the new leadership configuration, co-founders Kévin Alessandri and Maxime Feyeux will transition from daily operations to focus on their roles on the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215145193/en/ Mark Rothera, CEO TreeFrog Therapeutics Elsy Boglioli, Chair of the Board of TreeFrog Therapeutics, commented “On behalf of the Board, we are delighted to welcome Mark to TreeFrog. His 30+ years of biopharma leadership, including most recently, three biotech CEO roles in gene therapy and biologics, will be invaluable as we advance our Parkinson’s and liver
RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge® (omidubicel-onlv) for Second FDA-Approved Indication in Severe Aplastic Anemia (SAA)16.12.2025 09:00:00 CET | Press release
RoslinCT is performing technology transfer and will support commercial manufacture of Omisirge® for an additional indication following successful clinical trialsOmisirge® now FDA-approved for an expanded patient population in hematologyRoslinCT continues to support and advance multiple cell therapy projects at its Hopkinton, MA facility Ayrmid Ltd., the parent company of Gamida Cell Inc., a pioneering cell therapy company transforming cells into powerful therapeutics, and RoslinCT, a global leader in cell and gene therapy contract development and manufacturing, today announced the expansion of their strategic partnership to include the execution of a commercial supply agreement to support production of Omisirge® (omidubicel-onlv). Following positive clinical trial results, Omisirge® has received FDA approval for a second indication, broadening its use in the treatment of hematology patients. Under the commercial supply agreement, RoslinCT will complete technology transfer and support c
Echoworx Secures FSQS-Netherlands Certification, Strengthening Trust in Financial Data Protection16.12.2025 07:00:00 CET | Press release
Leading encryption provider deepens commitment to European financial sector with rigorous new supplier qualification, building on existing UK & Ireland certification. Echoworx, a global leader in email and data encryption, proudly announces it has achieved Financial Services Qualification System (FSQS) registered supplier status for the Netherlands. This certification powerfully demonstrates Echoworx’s commitment to the highest standards of security and compliance. This achievement expands on the company’s existing FSQS certification for the UK and Ireland, secured in 2020. By successfully completing the rigorous qualification for the Netherlands, Echoworx reinforces its alignment with the stringent demands of the European financial market. The FSQS system, managed by Hellios, provides a single, reliable standard for vetting third-party suppliers, streamlining procurement for major banks and financial institutions. Think of FSQS as a high-security passport for technology partners. It p
Nippon Electric Glass to Start World’s First Mass Production of Low-Carbon Pharmaceutical Glass Tubing Using an All-Electric Furnace16.12.2025 03:00:00 CET | Press release
Nippon Electric Glass Co., Ltd. (NEG)(TOKYO:5214), a global leader in specialty glass headquartered in Otsu, Japan, announced it will begin the world’s first mass production of pharmaceutical-grade glass tubing using an all-electric melting furnace. Commercial production is scheduled to start in December 2025 at its subsidiary in Selangor, Malaysia. This breakthrough introduces a new manufacturing model for pharmaceutical packaging. By combining NEG’s proprietary all-electric melting technology with renewable energy, CO2 emissions from glass tubing production can be reduced by up to 90%*1 compared with conventional fossil-fuel combustion furnaces. This positions NEG as a major supplier capable of delivering both high-performance borosilicate glass and a significantly lower carbon footprint, directly addressing global sustainability demands from pharmaceutical companies and regulators. NEG is a leading global supplier of arsenic-free, environmentally friendly borosilicate glass tubing f
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
